Avian leukosis virus subgroup J promotes cell proliferation and cell cycle progression through miR-221 by targeting CDKN1B

Virology. 2018 Jun:519:121-130. doi: 10.1016/j.virol.2018.04.008. Epub 2018 May 11.

Abstract

Avian leukosis virus subgroup J (ALV-J), a highly oncogenic retrovirus, causes leukemia-like proliferative diseases in chickens. microRNAs post-transcriptionally suppress targets and are involved in the development of various tumors. We previously showed that miR-221 is upregulated in ALV-J-induced tumors. In this study, we analyzed the possible function of miR-221 in ALV-J tumorigenesis. The target validation system showed that CDKN1B is a target of miR-221 and is downregulated in ALV-J infection. As CDKN1B arrests the cell cycle and regulates its progression, we analyzed the proliferation of ALV-J-infected DF-1 cells. ALV-J-infection-induced DF1 cell derepression of G1/S transition and overproliferation required high miR-221 expression followed by CDKN1B downregulation. Cell cycle pathway analysis showed that ALV-J infection induced DF-1 cell overproliferation via the CDKN1B-CDK2/CDK6 pathway. Thus, miR-221 may play an important role in ALV-J-induced aggressive growth of DF-1 cells; these findings have expanded our insights into the mechanism underlying ALV-J infection and tumorigenesis.

Keywords: Avian leukosis virus subgroup J; CDKN1B; Cell cycle; MiR-221.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Avian Leukosis / virology
  • Avian Leukosis Virus / classification
  • Avian Leukosis Virus / genetics
  • Avian Leukosis Virus / physiology*
  • Carcinogenesis / genetics
  • Cell Cycle / genetics*
  • Cell Cycle / physiology
  • Cell Line
  • Cell Proliferation*
  • Chickens / virology
  • Computational Biology
  • Cyclin-Dependent Kinase Inhibitor p27 / genetics*
  • Down-Regulation
  • Fibroblasts / physiology
  • Fibroblasts / virology
  • Host-Pathogen Interactions*
  • MicroRNAs / genetics*
  • Poultry Diseases / virology

Substances

  • MicroRNAs
  • Cyclin-Dependent Kinase Inhibitor p27